Tomsk, Russia

Veniamin Abramovich Khazanov

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.1

ph-index = 1


Location History:

  • Novosibirsk, RU (2018)
  • Tomsk, RU (2007 - 2019)

Company Filing History:


Years Active: 2007-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Veniamin Abramovich Khazanov: Innovator in Molecular Biology and Biochemistry

Introduction

Veniamin Abramovich Khazanov is a notable inventor based in Tomsk, Russia. He has made significant contributions to the fields of molecular biology, biochemistry, and biotechnology. With a total of 3 patents, Khazanov's work focuses on innovative compounds that exhibit promising therapeutic effects.

Latest Patents

Khazanov's latest patents include a compound known as 2-acetyl-6-(2-(2-(4-bromobenzylidene)hydrazinyl)thiazole-4-yl)-3,7,9-trihydroxy-8,9b-dimethyldibenzo[b,d]furan-1(9bh)-one. This compound demonstrates an inhibitory effect on the human tyrosyl-DNA-phosphodiesterase 1 enzyme. The invention aims to enhance the inhibitory action towards this enzyme, thereby increasing the number of potential inhibitors. Additionally, he has developed 2H-chromene derivatives that serve as analgesic agents, showcasing high activity and low toxicity for medical applications.

Career Highlights

Throughout his career, Khazanov has worked with various organizations, including Innovative Pharmacology Research OOO (iPhar) and Leofors. His research has led to advancements in drug development, particularly in the area of pain management and molecular inhibition.

Collaborations

Khazanov has collaborated with notable colleagues such as Nariman Faridovich Salakhutdinov and Olga Anatolyevna Luzina. These partnerships have contributed to the success of his research and the development of innovative solutions in the pharmaceutical field.

Conclusion

Veniamin Abramovich Khazanov is a distinguished inventor whose work in molecular biology and biochemistry has the potential to impact medical science significantly. His innovative patents and collaborations highlight his commitment to advancing therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…